InvestorsHub Logo
Followers 19
Posts 1607
Boards Moderated 0
Alias Born 08/26/2013

Re: learning curve post# 10293

Monday, 02/13/2017 3:09:21 AM

Monday, February 13, 2017 3:09:21 AM

Post# of 43784
You can't hinge everything up on the FDA's approval or disapproval of this particular drug at stage III. There's more to CVM then just this particular drug . FDA approval. If you read the 10-Q not only does the company have a functional approved manufacturing facility. Which can make the stock very ripe for an accusation . LEAPs it's also only in stage one. Stage two news is usually where micro bio pharmaceutical stocks really see their stock movement. At this low price you could easily see 100% to 40% returns within a week based on any variable change-.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News